Zacks Investment Research
06 Aug 2026, 16:46 UTC · 6w ago
Verdict
Headline leans bullish. We score MCK +0.80 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.80strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
McKesson Corporation reported Q1 fiscal 2027 adjusted EPS of $9.93, beating the Zacks Consensus Estimate of $9.44 by 5.2%.
So whatAn earnings beat combined with a 20% year-over-year increase in adjusted EPS typically drives positive short-term sentiment for the stock.
More positive than 76% of claims this week
McKesson's Q1 fiscal 2027 revenues rose 8% to $105.38 billion, surpassing the consensus estimate of $104.39 billion.
Continue reading
5 related stories
More positive than 85% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 62% of claims this week
GLP-1 medication distribution revenues increased 24% year over year to $15 billion.
More positive than 62% of claims this week
GAAP EPS declined 18% to $5.15 due to a $293 million redemption value adjustment in the Medical-Surgical Solutions segment.
More negative than 66% of claims this week
Which stocks this story touches
More positive than 85% of ticker scores this week
Company reported adjusted EPS and revenue beats, raised guidance, and saw an after-hours share price increase.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+1.6%
Price agrees with the score
$891.23 vs $877.23 close before publication (Aug 5) · not market-adjusted
MCK chart →